Overview
Our guest in this episode is Kinneret Shefer, co-founder and CEO of AgTech startup GeneNeer. Kinneret shares the founding of GeneNeer, driven by her shift from pure RNA research to market-driven innovation. GeneNeer aims to revolutionize crop breeding by drastically shortening trait development time using fast, tissue culture-based gene editing platforms. Kinneret compares her vision for GeneNeer to Pfizer's rapid vaccine development during COVID-19, enabling fast responses to agricultural challenges like drought or new pests. GeneNeer's "super line" platform allows rapid, iterative trait development with backup options, while their AI-supported platform enables precise, tissue- and time-specific gene editing without introducing foreign DNA. GeneNeer's business model includes custom collaborations and independent product development.
More:
|
|
Dr. Kinneret Shefer is the CEO and Co-founder of GeneNeer. She is a researcher and an entrepreneur, innovating ground-breaking platforms capable of streamlining and embellishing the process of gene editing for crop enhancement. She earned a Ph.D. in Genetics from The Hebrew University of Jerusalem and received a Fulbright Post-doctoral Scholarship to research RNA Structure and Function at the University of California – Santa Cruz. Kinneret holds three patents in her name, raised millions of US dollars in venture capital and signed collaboration agreements, including with a Tier-1 company. In her spare time, she loves sports and hiking, is a social activist and an advocate for women in the sciences and leadership.
|
Share on
